Use of levocetrizine in the management of type IV hypersensitivity to lidocaine: a case report
DOI:
https://doi.org/10.18203/2319-2003.ijbcp20214511Keywords:
Lidocaine, Allergy, LevocetrizineAbstract
Lidocaine is a commonly used local anesthetic in the field of dentistry. It has been known to cause allergic reactions, mainly immunoglobulin (IgE)-mediated and T-cell –mediated type IV reactions, which require the use of alternative drugs without adverse effects. Here we present the case of a 29 year old female patient who developed Type IV hypersensitivity reaction in the vicinity of the injection site after the administration of lidocaine local anesthetic for performing exodontia. Levocetrizine tablet was prescribed in order to relieve the symptoms of the reaction. Levocetrizine is a selective, potent, oral histamine H(1) receptor antagonist that is used for the symptomatic treatment of allergic rhinitis and chronic idiopathic urticaria. It has been reported to be effective and generally well tolerated by the patients. In our case also it was able to cure Type IV hypersensitivity reaction to lidocaine without producing any adverse events. Apart from curing allergic rhinitis and urticaria, levocetrizine is a wonderful option for treating Type IV hypersensitivity reaction to a local anesthetic, and it hardly produces any adverse effect. More cases are required to be reported in the future in order to support this article.
References
Batinac T, Sotošek Tokmadžić V, Peharda V, Brajac I. Adverse reactions and alleged allergy to local anesthetics: analysis of 331 patients. J Dermatol. 2013;40(7):522-7.
Finder RL, Moore PA. Adverse drug reactions to local anesthesia. Dent Clin. 2002;46(4):747-57.
Speca SJ, Boynes SG, Cuddy MA. Allergic reactions to local anesthetic formulations. Dental Clinics of North America. 2010;54(4):655-64.
Lee J, Lee JY, Kim HJ, Seo KS. Dental anesthesia for patients with allergic reactions to lidocaine: two case reports. J Dent Anesthesia Pain Med. 2016;16(3):209-12.
Dey M, Mishra BP, Awasthi D, Sahoo A. Articaine as an alternative in lidocaine allergy: Case report of a seventy year old male patient. Int J Surg Case Reports. 2020;77:941-3.
Minciullo PL, Paolino G, Vacca M, Gangemi S, Nettis E. Unmet diagnostic needs in contact oral mucosal allergies. Clin Molecular Allergy. 2016;14(1):1-8.
Estrada-Rodriguez JL, Rodríguez-Paredes A, Latasa M, Perez-Laiz JL. Delayed hypersensitivity to lidocaine cross-reactivity with others amide-type anesthetics. Int J Aller Medcations. 2015;1(007).
Mackley CL, Marks JG, Anderson BE. Delayed-type hypersensitivity to lidocaine. Arch Dermatol. 2003;139(3):343-6.
Hair PI, Scott LJ. Levocetirizine. Drugs. 2006;66(7):973-96.
Tillement JP. A low distribution volume as a determinant of efficacy and safety for histamine (H1 antagonists. Allergy. 1995;50:12-6.
Potter PC, Study Group. Levocetirizine is effective for symptom relief including nasal congestion in adolescent and adult (PAR) sensitized to house dust mites. Allergy. 2003;58(9):893-9.
Hulhoven R, Rosillon D, Letiexhe M, Meeus MA, Daoust A, Stockis A. Levocetirizine does not prolong the QT/QTc interval in healthy subjects: results from a thorough QT study. Euro J Clin Pharmacol. 2007;63(11):1011-7.
